Literature DB >> 6769035

A review of the coordinated research effort on the comparison of test systems for the detection of mutagenic effects, sponsored by the E.E.C.

I D Adler.   

Abstract

Under the Environmental Research Programme of the Commission of the European Communities a coordinated comparative test programme was started to assess the mutagenic effects of chemicals in as many different assay systems as possible. A preliminary report is given on the results for 5 compounds selected by the Contact Group "Genetic Effects of Chemicals". 11 laboratories contributed data from tests in their expertise. The compounds were methyl methanesulfonate (MMS), N-nitrosodiethylamine (DEN), mitomycin C (MC), procarbazine (Natulan) and atrazine. The results of testing these 5 compounds in more than 20 test systems are still incomplete but some observations can be made at this time. MMS has been shown to be mutagenic in every system used in this collaborative effort which is not surprising in view of the fact that MMS is a widely used reference mutagen that does not require metabolic activation. Among the indirect mutagens which were tested, MC has been shown to be mutagenic with almost every system which has been applied. DEN which requires microsomal activation gave positive results in most submammalian systems as well as in mammalian cells in culture when the S9 fraction of liver homogenate was added. However, in whole mammals most results were negative. One study suggests that the difference in the results with DEN may be due to the short biological half-life of the mutagenically active metabolite. Procarbazine was negative in the microbial tests but gave a positive response in mammalian cells in culture, in Drosophila and in mammals. Atrazine has only been subjected to a limited amount of testing but the results indicate that plant metabolic activation is required in vitro, and that activation to a mutagenic metabolite also occurs in mammals independent from liver enzymes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769035     DOI: 10.1016/0165-1161(80)90234-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Metabolic profile of atrazine and N-nitrosoatrazine in rat urine.

Authors:  G Meli; R Bagnati; R Fanelli; E Benfenati; L Airoldi
Journal:  Bull Environ Contam Toxicol       Date:  1992-05       Impact factor: 2.151

2.  Genotoxicity assessment of atrazine and some major metabolites in the Ames test.

Authors:  M A Butler; R E Hoagland
Journal:  Bull Environ Contam Toxicol       Date:  1989-12       Impact factor: 2.151

3.  Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems.

Authors:  F H Sobels
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

4.  Induction of gene mutations in germ cells of the mouse.

Authors:  U H Ehling
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

5.  Activating and inactivating reactions controlling 2-naphthylamine mutagenicity.

Authors:  B S Bock-Hennig; D Ullrich; K W Bock
Journal:  Arch Toxicol       Date:  1982-09       Impact factor: 5.153

6.  Clastogenic effect of the psychotropic drug thioridazine on human chromosomes in vivo.

Authors:  R Saxena; Y R Ahuja
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Simultaneous detection of changes in chromosome number, gene conversion and intergenic recombination during mitosis of Saccharomyces cerevisiae: spontaneous and ultraviolet light induced events.

Authors:  M S Esposito; D T Maleas; K A Bjornstad; C V Bruschi
Journal:  Curr Genet       Date:  1982-10       Impact factor: 3.886

8.  Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence.

Authors:  James W Simpkins; James A Swenberg; Noel Weiss; David Brusick; J Charles Eldridge; James T Stevens; Robert J Handa; Russell C Hovey; Tony M Plant; Timothy P Pastoor; Charles B Breckenridge
Journal:  Toxicol Sci       Date:  2011-07-18       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.